• -
595 Results
Screening patient for non-medical needs
Screening Patients for Non-Medical Needs Is Valuable Even When Clinicians Can’t Resolve Identified Needs
Medical providers are increasingly asking patients about their access to food, housing, and transportation. In this commentary, fellow Elena M. Marks explores how this type of screening for non-medical needs offers significant benefits for both patients and providers — even when providers cannot address those needs.
Elena M. Marks June 21, 2024
Voter holds envelope in hand above vote ballot
How Will Gaza and Ukraine Shape the 2024 US Presidential Election?
Two specific issues — the Russia-Ukraine war and the Israel-Hamas war — have propelled foreign policy to the forefront of this year’s election. Both conflicts are ongoing and have severely tested Biden and his foreign policy team, and ahead of November, Biden has little room for error.
Joe Barnes June 17, 2024
An Urgent Call for Clear and Fair Law Enforcement Guidelines and Procedures for Research Security
Recent federal research security initiatives have put the U.S. at risk of losing its lead in science and technology, write senior fellow Neal F. Lane, Steven Pei, and Jeremy Wu. They lay out a path toward clear, fair policy that safeguards America’s security and competitiveness while fostering a welcoming research environment for foreign talent.
Neal F. Lane, Steven Pei, Jeremy Wu May 31, 2024
China trade relations
Beyond US Unilateralism: Rethinking the Response to China’s Trade Practices
While the U.S. has tried to appear assertive in taking action against China’s trade practices, this strategy has yielded limited results. In a new commentary, fellow Simon Lester summarizes current U.S. policies addressing China’s trade conduct and advocates for the U.S.’ revitalized engagement with the World Trade Organization’s dispute settlement system.
Simon Lester May 29, 2024
Medical law
Promoted Yet Unproven: How State Laws Expand Access to Unchecked Stem Cell Interventions
The safety and efficacy of many stem cell treatments remain unproven by the FDA, yet state laws promote access and use of these unchecked and potentially harmful treatments. Fellow Kirstin R.W. Matthews summarizes her recent publication in a new commentary — outlining public health consequences of these state laws and calling for scientific societies’ advocacy in state policymaking.
Kirstin R.W. Matthews May 13, 2024
Texas State Capitol Building in Austin, TX
Where Are the Majority Who Support Vaccines?
The number of anti-vaccine bills filed in Texas has risen, yet many Texans support vaccine policy. Fellow Kirstin R.W. Matthews and nonresident scholar Rekha Lakshmanan examine the stakes of legislative engagement in public health initiatives and provide a call to action for Texans to embrace public health as an act of freedom.
Kirstin R.W. Matthews, Rekha Lakshmanan April 29, 2024